Post-approval studies (Phase 4)Study completedNCT01443845
What this trial is testing
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
Who this might be right for
COPDCOPD ExacerbationLung Diseases+4 more
AstraZeneca 2,354